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Recently, there has been a resurgence of interest in the
use of contrast-enhanced echocardiography as a means
of noninvasively assessing myocardial perfusion. How-
ever, if injections of echocardiographic contrast agents
are to be used for this purpose it is essential that they
are not intrinsically toxic to the heart. In this study, the
left ventricular end-systolic wall stress-rate-corrected
velocity of fiber shortening relation, a load independent
index of contractility, was studied in nine dogs. Two-
dimensional and targeted M-mode echocardiographic as
wellas central aortic pressure tracings were made during
echocardiographically gated, pressure- and volume-con-
trolled aortic root injections of nonsonicated and soni-
cated Renografin-76, saline and dextrose 70% (n = 6),
and sonicated and hand-agitated Renografin-76/saline
mixture (n = 5). Two of nine dogs received all agents.
Off-line computer videodensitometric analysis docu-
mented myocardial perfusion. In all cases, data were
obtained at control and 5 and 15 seconds after injection.
Additional data were collected at 25 seconds after in-
jection for the Renografin-76/saline mixture.
Alterations in contractility were measured relative to
Contrast echocardiography has been used in a variety of
clinical settings to detect valvular regurgitation, assess in-
tracardiac shunts, identify cardiac chambers and measure
cardiac output (1-5). Recently, there has been a resurgence
of interest in the use of contrast-enhanced two-dimensional
echocardiography as a means of noninvasively defining
myocardial perfusion (6-16). This is particularly relevant
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control as changes in rate-corrected velocity of fiber
shortening after afterload (measured as end-systolic wall
stress) was eliminated as a confounding variable. Under
no condition did saline or Renografin-76 cause altera-
tions in left ventricular contractility. Nonsonicated and
sonicated dextrose 70% increased left ventricular con-
tractility at 15 seconds but not at 5 seconds after injec-
tion. Hand-agitated Renografin-76/saline mixture in-
duced a negative inotropic effect at 5 and 15 seconds
after injection. This effect was gone by 25 seconds after
injection. Similar volumes of sonicated Renografin-
76/saline mixture did not change contractility.
Thus, I) individual echo contrast agents influence left
ventricular contractility; 2) the addition of sonication to
a carrier solution does not influence its effect on ven-
tricular contractility; and 3) hand-agitated echo contrast
agents transiently depress left ventricular contractility;
the use of sonication to produce smaller and more uni-
formly sized microbubbles overcomes this adverse hemo-
dynamic effect.
(J Am Coli CardioI1987;9:910-9)
with the current availability of widely used interventional
procedures such as coronary thrombolysis (17) and percu-
taneous transluminal coronary angioplasty (18). With the
development of these techniques the need to delineate viable
from nonviable myocardium in patients with ischemic heart
disease has become critically important (19,20). If echo-
cardiographic contrast agents are to be used to assess myo-
cardial perfusion, especially as it relates to ventricular per-
formance, it is essential that they not be intrinsically toxic
to the heart.
Echocardiographic contrast agents comprise a variety of
carrier solutions in which microbubbles are suspended. These
microbubbles can be considered ultrasound reflectors re-
sulting in contrast effect while carrier solutions provide the
medium that enables persistence of microbubbles. Sonica-
tion of carrier solutions is an ultrasound process that gen-
erates microbubbles that are sufficiently small, uniform in
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size and stable to readily traverse capillary beds in an un-
hindered manner (21,22). Conversely, hand-agitated solu-
tions contain larger microbubbles which may interrupt the
microcirculation (21).
Contrast agents have been reported to transiently affect
systemic blood pressure, heart rate, myocardial function and
left ventricular volumes (23-29). Because traditional in-
dexes of ventricular performance are affected by all of these
variables, they are unable to separate derangements in con-
tractility from alterations in left ventricular loading condi-
tions. To avoid this limitation, load-independent sensitive
indexes of contractility (30-33) were used in this study to
assess the effects of carrier solutions (alone and with mi-
crobubbles) on left ventricular contractility.
Methods
Surgical preparation and instrumentation. Nine mon-
grel dogs (18.5 to 35 kg in weight) were premedicated with
subcutaneous morphine (5 mg/kg) followed by anesthesia
with intravenous alpha-chlorolose (100 mg/kg). After en-
dotracheal intubation, room air ventilation was maintained
with a Harvard volume respirator. A micromanometer-tipped
catheter was advanced in a retrograde manner by way of
the left femoral artery and positioned in the ascending aorta.
This catheter which provided high fidelity central aortic
pressures was also used for measurements of left ventricular
ejection time and end-systolic pressures. A second catheter
OF pigtail) was modified by occluding the distal tip and
advanced retrogradely by way of the right femoral artery.
This latter catheter was positioned under fluoroscopic or
ultrasound guidance in the proximal aortic root at the level
of the coronary arteries and used for bolus injections of
sonicated and nonsonicated as well as hand-agitated contrast
agents. The right femoral vein was cannulated with a large
bore catheter and used for continuous fluid hydration. Elec-
trocardiogram and central aortic pressures were monitored
throughout the experiment. The micromanometer-tipped
catheter was calibrated with a mercury manometer before
insertion. In five dogs the experiment was conducted as a
closed chest preparation. In the other four, the experiment
was conducted after a median sternotomy had been com-
pleted. The latter was performed to place flow probes around
the left anterior descending coronary artery.
Experimental design. All animals were premedicated
with intravenous atropine (0,010 to 0,015 mg/kg body weight)
to abolish the vagally mediated bradycardia commonly as-
sociated with morphine-chloralose anesthesia. Ultrasound
imaging (Hewlett-Packard) was performed with a 5 MHz
ultrasound transducer. Cross-sectional two-dimensional
echocardiographic images acquired at the level of the tips
of the anterior leaflet of the mitral valve were recorded on
videotape during end-expiration, Simultaneous left ventric-
ular two-dimensional and targeted M-mode echocardio-
grams, electrocardiograms and high fidelity central aortic
pressures were recorded under baseline conditions, In six
dogs, combined echocardiographic and central aortic pres-
sures were recorded during pressure controlled and electro-
cardiographic-gated (Medrad, Mark IV) aortic root injec-
tions of 5 to 7 cc of nonsonicated and sonicated 0.9% saline,
Renografin-76 (meglumine diatrizoate and sodium diatri-
zoate) , and dextrose 70%. Two of these dogs as well as
three additional dogs received intraaortic injections of 5 to
7 cc of hand-agitated as well as sonicated Renografin-76/saline
mixture. In all cases, data were assessed at control, 5 sec-
onds and 15 seconds after injection of the echocardiographic
contrast agent. In the case of the Renografin-76/saline mix-
ture, additional data were recorded at 25 seconds after in-
jection. Intraaortic injections of contrast agents were per-
formed in all experiments in the order described previously.
Figure I is a still frame from a simultaneously recorded
two-dimensional and targeted M-mode echocardiogram ac-
quired during an intraaortic root injection of Renografin-76.
Contrast is present in the myocardium by 5 seconds with
complete clearance of contrast by 15 seconds. Figure 2 is
an example of a two-dimensional targeted M-mode echo-
cardiogram obtained during an intraaortic injection of dex-
trose 70%. Contrast effect can be visualized in the inter-
eTR 5 sec
Figure 1. Still frames showing two-
dimensional and targeted M-mode
echocardiograms acquired during an
intraaortic root injection of Reno-
grafin-76. The left ventricle is visu-
alized in a tomographic cut at the level
of the papillary muscles. Note the
presence of contrast in the myocar-
dium by 5 seconds after injection with
complete clearance of contrast by 15
seconds after injection. CTR = con-
trol.
15 sec
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Figure 2. Two-dimensionally tar-
geted M-mode echocardiogram ob-
tained during an intraaortic injec-
tion of dextrose 70%. There also
is a simultaneously recorded cen-
tral aortic (AO) pressure and elec-
trocardiogram (ECG) tracing.
Contrast enhancement of both the
interventricular septum (IVS) and
left ventricular posterior wall
(LVPW) are seen after the intraaor-
tic injection. Spillover of contrast
into the left ventricular cavity is
noted.
ventricular septum and posterior wall immediately after the
intraaortic injection; spillover of contrast material into the
left ventricular cavity is also noted.
Echocardiographic contrast agent preparation. The
microbubble solutions used as echo contrast agents were
prepared in a standardized manner and adjusted to physi-
ologic pH before intraaortic injection. Sonicated solutions
were prepared with a sonicator unit (Model 220 Heat Sys-
tems/Ultrasonics) (21). A 10 ml plastic disposable syringe
was filled with 8 ml of either saline, Renografin-76, dextrose
70% or Renografin-76/saline mixture. The syringe was then
positioned so that 1f2 inch (1.27 em) of the horn portion of
the sonicator unit was submerged in the fluid. With the
energy settings at 50% duty (that is, 180 W/cm), energy
was applied for 30 seconds. Immediately after the energy
was turned off, the plunger was reinserted into the syringe
and the microcavitated solution injected into the aortic root
through the pigtail catheter positioned in the proximal aortic
root. Hand-agitated solutions were prepared using the method
described by Tei et al. (23) in which a 10 ml syringe filled
with 4 ml of saline, 4 ml of Renografin-76 and approxi-
mately 0.1 to 0.2 ml of air was used. The solution was then
agitated by rapid transfer from one syringe to another (20
times) through a plastic three-way stopcock. After removal
of visually apparent gaseous macrobubbles, the solution was
injected using an electrocardiographically gated, volume-
and pressure-controlled power injector. Assessment of mi-
crobubble size was performed in a previously described
manner using light microscopy (all contrast agents) (21) and
a laser particle counter (all contrast agents except Reno-
grafin-76/saline mixture) (34).
Definition of contrast enhancement. To quantitate the
degree of myocardial opacification, videotapes were ana-
Iyzed using an off-line digitizing computer (Quantic 1200,
Bruce Franklin, Inc.). An edge detection algorithm within
the unit allowed rapid, accurate detection of the left ven-
tricular endocardial and epicardial borders throughout the
entire cardiac cycle for periods up to 30 seconds. Each
tomographic cut of the heart was radially divided into 32
regions. The areas within these regions were analyzed using
videodensitometric techniques and represented by plotting
the average pixel intensity per region versus time (35). To
ensure adequate contrast effect of the analyzed injections,
only those that caused an increase of at least two gray levels
of pixel intensity (with the exception of sonicated saline) in
75% of the left ventricular segments were selected to assess
the effects of echocardiographic contrast agents on ventric-
ular contractility. As previously published (22), sonicated
saline is a medium that does not enable the persistence of
microbubbles generated by sonication. Consequently, no
myocardial contrast effect was noted after intraaortic injec-
tions of sonicated saline.
The present video-intensity analysis was based on earlier
in vitro determinations of direct radiofrequency backscatter
obtained from sonicated microbubbles of known concentra-
tions and diameters (36,37). Subsequently, calibrations of
the microbubble backscatter characteristics and the off-line
computer software gray levels were performed (34).
Measurements and data analysis. The peak of the R
wave of the electrocardiogram (ECG) and the dicrotic notch
of the high fidelity central aortic pressure tracing were used
to designate end-diastole and end-systole, respectively. Left
ventricular end-systolic and end-diastolic dimensions (Des
and Oed) and wall thicknesses (h.; and hed ) were measured
from the targeted M-mode echocardiographic recordings as
the mean value of three cardiac cycles. The left ventricular
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Left ventricular meridional wall stress was calculated
using the following angiographically validated formula (35):
(Pes) (Des) (1.35)
(hes) (I + hes (4»)'Des
percent fractional shortening (%aD) was calculated as Oed
minus Des divided by Oed' The left ventricular end-systolic
pressure (PeS> and ejection time (LVET) were measuredfrom
the high fidelitycentral aortic pressure tracings in the stand-
ard fashion and taken as the average of three beats. Left
ventricular ejection time was corrected to a heart rate of 60
beats/min by dividing by the square root of the preceding
RR interval.
The rate-corrected left ventricular velocity offiber short-
ening (Vcf.) was calculated as
where end-systolic wall stress «(Tes) is in g/cm", end-systolic
pressure (Pes) is in mm Hg, end-systolic wall thickness (hes)
and dimension (Des) are in em and 1.35 is a factor to convert
end-systolic pressure from mm Hg to g/crrr'.
The effects of echocardiographic contrast agents on left
ventricular contractility were assessed using end-systolic
stress-rate corrected velocity of fiber shortening data ac-
quired for each dog. This relation is a sensitive index of
left ventricular contractility which is preload and heart rate
independent and incorporates afterload (30). Comparisons
Figure 3. Plot of our previously reported left ventricular (LV)
end-systolic stress-rate-corrected velocity of fiber shortening (Vcf.)
relation acquired in 10normal dogs under baseline conditions and
during afterload manipulation with methoxamine. There is an in-
verse relation between afterload and overall ventricular perform-
ance. Vet, = rate-corrected velocity of LV fiber shortening.
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Figure 4. Representative left ventricular (LV) end-systolic wall
stress-rate-corrected velocity of fiber shortening (Vel) data show-
ing method of data analysis. See text for detailed explanation.
were made using a.; - Vcf, data previously acquired over
a wide range of afterload in 10 dogs using methods similar
to those employed in this study (Fig. 3) (36). With this as
a reference, it was possible to determine left ventricular
contractility for an individual dog relative to predicted val-
ues for a normal canine population. This was done using
the deviation in left ventricular corrected velocity of fiber
shortening (VcO units above or below the mean regression
line at a given level of afterload (that is, (Tes)'
Figure 4 illustrates this method ofdata analysis. In panel
A, left ventricular rate-corrected velocity of fiber shortening
(Vcf.) is plotted on the y axis and end-systolic stress «(TeS>
is on the x axis. The mean (Tes-Vce. line from Figure 3 is
shown. Point A is a control (Tos - Vcf., value for a repre-
sentative dog. The vertical distance between point A and
the reference line. shown as aA. is the difference in this
dog's baseline left ventricular contractile state relative to
the mean contractile state for a normal canine population.
In panel B, an intervention caused a shift in the (To,- Vcf,
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Table l. Effe ct of Dextrose 70% o n Left Ventricular Hemodynamic s in S ix Dogs
Nonsonicated Sonicated
HR
Po,
Do,
Dod
%~D
ver,
Control
94 ± 24
IQ5 ± 16
2.29 ± 0 .21
3.45 ± 0 .19
33.8 ± 3.9
1.23 ± 0 . 13
36 ± 8
5 Seconds
94 ± 20
103 ± 17
2.29 ± 0 .24
3.4 7 ± 0 .22
33 .9 ± 4 .0
1.23 ± 0.11
36 ± 9
15 Seconds
101 ± 24
93 ± 23
2. 15 ± 0 .24
3.52 ± 0.26
39.1 ± 4 .3*
1.40 ± 0 . 12t
29 ± 10
Control
94 ± 25
106 ± 14
2.30 ± 0 .18
3.46 ± 0.21
33.5 ± 2.9
1.24 ± 0 .12
37 ± 6
5 Seconds
88 ± 23
101 ± 15
2.29 ± 0. 19
3.50 ± 0.24
34.6 ± 2.6
1.28 ± 0 . 11
34 ± 7
15 Seconds
91 ± 24
102 ± 13
2.22 ± 0 .22
3.54 ± 0 .26
37. 3 ± 3.3t
1041 ± 0 .13+
33 ± 6
*p < 0 .025 versus control ; t p < 0.01 versus control ; :j:p < 0.001 versus control; %~D = percent fractional shorten ing; Dod = left ventricular end-
diastolic dimension (ern): Do, = left ventr icular end-systolic dimension (ern); a-; = left ventricular end-sy stolic wall stress (g/cm-) : HR = heart rate
(beat s/min); Po, = left ventricular end- systolic pressure (mm Hg); Vcf, = rate-corrected velocity of fiber shortenin g (circumferences/s).
value from point A to point B. This intervention resulted
in a 20% increase in left ventricular performance as mea-
sured by Vcf. . Without the aid of a load-independent index
of left ventricular contractility one would erroneously con-
clude that this intervention resulted in augmentation of left
ventricular contractility . However , when left ventricular af-
terload (that is, end-systolic wall stress) is considered, it
becomes apparent that this improvement occurred under
very different afterload conditions. The intervention (point
B) was associated with a 40% decline in end-systolic wall
stress when compared with baseline point A. However, the
vertical distance between each point and the mean reference
contractility line is identical. Therefore, when afterload was
eliminated as a confounding variable, there was no alteration
in left ventricular contractility despite an increase from base-
line rate-corrected velocity of fiber shortening (Vcf.) . In this
case? all improvement in left ventricular performance was
accounted for solely on the basis of afterload reduction.
Statistical considerations. Each dog served as its own
control. Statistical significance was tested for data obtained
at control , 5 seconds, 15 seconds and, when appropriate,
25 seconds after injection of the various contrast agents
using a paired t test and then employing a Bonferroni cor-
rection factor for multiple comparisons. Statistically sig-
nificant differences were accepted at a probability (p) value
less than O.05/K , where K = number of comparisons (that
is, K = 2 for nonsonicated and sonicated saline, Renografin-
76 and dextrose 70% and K = 3 for the hand-agitated and
sonicated Renografin-Zo/saline mixture) from injections per-
formed in six and five dogs, respectively. Data presented
in Figures 5 and 6 also represent mean grouped data. Left
ventricular contractile state was evaluated using our pre-
viously published normal values for the end-systolic
stress-rate-correct~d velocity of fiber shortening relation as
a basis for comparison (38).
Results
Quantitative assessment of bubble size and agent
osmolarity. Sonicated Renografin-76 had a small mean
bubble size (laser = 4.5 :±: 2.8 J-Lm ; light microscopy =
10 :±: 4 J-Lm) in association with an osmolarity of 1,760
mosmol. The mean bubble size of dextrose 7Q% was similar
to that of Renografin-76 (4.6 :±: 2.8 J-Lm by laser; 8 ± 3
J-Lm by light microscopy). However, dextrose 70% had very
high osmolarity (3,520 mosmol). Hand-agitated Renografin-
76/saline mixture had the largest mean bubble size (16 :±:
16 J-L by light microscopy) as well as the greatest variability
in size. The osmolarity of the hand-agitated Renografin-
76/saline mixture was the lowest at approximately I ,000
mosmol.
Table 2. Effect of Renografin-7 6/Saline Mixture o n Left Ventricular Hemodyn amics in Five Dogs
Hand-Agitated Sonicated
Contro l 5 Second s 15 Seconds 25 Seconds Contro l 5 Second s 15 Seco nds 25 Second s
HR 78 ± 6 82 ± 15 83 ± 15 82 ± 9 73 ± 14 74 ± 14 78 ± I I 84 ± 10
Po. 100 ± 9 10 ) ± 13 105 ± 10 104 ± 7 105 ± 6 102 ± 8 104 ± 7 101 ± 9
Do. 2.03 ± 0.25 2 .~3 ± 0.31 2.26 ± 0.35 2.08 ± 0.27 2. 10 ± 0.24 2. 10 ± 0.25 2.10 ± 0 .24 2.04 ± 0. 17
D,,, 3.28 ± 0.30 3.29 ± 0.29 3.30 ± 0.29 3.27 ± 0 .29 3.3 1 ± 0.26 3.29 ± 0.28 3.31 ± 0 .2 1 3.24 ± 0. 12
%~D 38.0 ± 2.1 32.4 ± 3.3t 3 1.6 ± 4 .5* 36.7 ± 2.6 36 .8 ± 3.1 36.3 ± 3.8 36 .6 ± 3.5 36.9 ± 3. 1
Vc( 1.36 ± 0.08 1.12 ± O.IOt 1.09 ± 0 .10* 1.33 ± 0 .08 1.34 ± 0.11 1.34 ± 0 .11 1.33 ± 0.12 1.34 ± 0 .13
fIe .. 32 ::t: 7 39 ± 13 41 ± 14 34 ± 9 35 ± 7 34 ± 8 35 ± 8 32 ::t: 7
*p < 0.017 versus control.tp < 0 .00 I versus control. Abbreviations as in Table I.
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Figure 6. A, Average data obtained after intraaortic injections of
nonsonicated (NON SON) and sonicated (SON) dextrose 70%
obtained in six dogs. No change in contractile state was noted lit
5 seconds after injection. However, by 15 seconds after injebtion
left ventricular contractility was increased in conjunction with a
decrease in afterload. B, Average data obtained after injeciion of
hand-agitated Renografin-76 (RENO-76)/saline mixture obtained
in five dogs. An acute negative inotropic effect was evident at 5
and 15 seconds afterinjection. Contractile statereturned tobaseline
by 25 seconds after injection. When a similar volume of sonicated
Renografin-76/saline mixture was injected (thereby generating
smaller microbubbles), no changes in contractility were noted.
Otherabbreviations as in Figure 5.
tered together representing no change in either contractility
or afterload with this agent.
Renografin-76. Intraaortic injections of sonicated and
nonsonicated Renografin-76 did not change heart rate, aortic
pressures, end-systolic or end-diastolic dimension or overall
left ventricular performance. Afterload as quantitated by
end-systolic wall stress was not altered (Fig. 5B). Both
sonicated and nonsonicated Renografin-76 resulted in data
points which were equidistant from the mean canine con-
tractility line. This indicates that at the doses used in this
study Renografin-76 induced at most a trivial decrease in
left ventricular afterload without causing alterations in con-
tractile state.
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Figure 5. A, Average leftventricular (LV) end-systolic wall stress
(Tes)-rate-corrected velocity of fiber shortening (Vcr) relation ob-
tained at control and 5 and 15 seconds after intraaortic injections
of nonsonicated (NON SON) (opensymbols) andsonicated (SON)
saline injections (closed symbols) in six dogs. The nonsonicated
and sonicated data are clustered together representing no change
in either contractility or afterload with this agent. B, Mean data
obtained using sonicated and nonsonicated Renografin-76 were
equidistant from the mean canine contractility line (n = 6). This
indicates that at the volumes used in this study. Renografin-76
induced at most a trivial decrease in leftventricular afterload with-
out causing alterations in left ventricular contractile state.
Effect of Contrast Agents on Left
VentricuLar Contractility
Saline. Intraaortic injections of sonicated and nonsoni-
cated saline did not change heart rate, aortic pressures, left
ventricular dimensions or overall ventricular performance
(as assessed by shortening fraction and rate-corrected ve-
iocity of fiber shortening [V cf,D. Afterload as measured by
end-systolic wall stress (TeJ was unaltered. Figure 5A shows
the mean a.; - Vcf, points obtained from the six dogs who
received intraaortic injections of nonsonicated and sonicated
saline. The mean (Tes - Vcf, points obtained immediately
after injection of nonsonicated and sonicated saline are clus-
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Dextrose 70%. The hemodynamic data obtained under
conditions at rest as well as after intraaortic injections of
nonsonicated and sonicated dextrose 70% are summarized
in Table I, No changes in heart rate, ventricular end-systolic
pressure or dimension, percent fractional shortening, left
ventricular rate-corrected velocity of fiber shortening (Vcf.)
or end-systolic wall stress (ueS> occurred for either nonson-
icated or sonicated dextrose 70% at 5 seconds after injection,
By 15 seconds after injection, a trend toward decreased
afterload (that is, end-systolic wall stress) relative to control
(36 ± 8 to 29 ± 10 g/cm"; p = 0,04) was seen with
nonsonicated dextrose 70%, Overall left ventricular per-
formance improved significantly with percent fractional
shortening increasing by 16% (33,8 ± 3,9 to 39, I ± 4,3;
P < 0,025) and rate-corrected velocity of fiber shortening
by 14% (\.23 ± 0.13 to 1.40 ± 0,12; P < 0.01), Similarly,
sonicated dextrose 70% at 15 seconds after injection tended
to decrease end-systolic wall stress with an II % decrease
relative to control (37 ± 6 to 33 ± 6 g/crrr'; p = 0.03),
At the same time, percent fractional shortening increased
by II % (33.5 ± 2,9 to 37,3 ± 3.3; p < 0.01) and rate-
corrected velocity of fiber shortening by 14% (1,24 ± 0,12
to 1.41 ± 0.13; p < 0.00 I), Figure 6A displays the a., -
Vcf, data obtained with intraaortic injections of nonsoni-
cated and sonicated dextrose 70%, No change in contractile
state was noted at 5 seconds, However, by 15 seconds left
ventricular contractility increased in conjunction with de-
creased afterload.
Renografin-76/saline mixture. Table 2 shows the
hemodynamic data obtained under conditions at rest as well
as after intraaortic injections of hand-agitated and sonicated
Renografin-76/saline mixture. The hand-agitated mixture
decreased percent fractional shortening by 15% at 5 seconds
(38.0 ± 2, I to 32.4 ± 3,3; p < 0,001) and by 17% at 15
seconds (38.0 ± 2,1 to 3\.6 ± 4.5; p < 0,017 versus
control), Rate-corrected velocity of fiber shortening de-
creased by 18%at5seconds(l,36 ± 0.08 to \.12 ± 0,10;
P < 0.001) and by 20% at 15 seconds (1.36 ± 0,08 to
1.09 ± 0.10; p < 0.017 versus control). Both of these
measures of overall left ventricular performance returned to
baseline by 25 seconds after injection. These changes in
ventricular shortening characteristics occurred in conjunc-
tion with a slight but not statistically significant increase in
end-systolic wall stress at 5 seconds (32 ± 7 to 39 ± 13
g/crrr'; p = 0,06) and at 15 seconds (41 ± 14 g/cm"; p =
0.05 versus control). End-systolic stress returned to baseline
values by 25 seconds after injection, When a similar volume
of Renografin-76/saline mixture was sonicated before in-
jection, no changes in percent fractional shortening, rate-
corrected velocity of fiber shortening (VcO or end-systolic
wall stress (ues> were noted. Figure 6B shows the mean Ues
- Vcf, data obtained after intraaortic injections of hand-
agitated Renografin-76/saline mixture. An acute negative
inotropic effect was uniformly evident at 5 seconds and 15
seconds after injection; contractility returned to baseline by
25 seconds after injection, When sonicated Renografin-
76/saline mixture rather than hand-agitated solution was
used, no changes in left ventricular performance, end-sys-
tolic wall stress or contractile state were noted.
Discussion
Despite the numerous reports on the clinical applications
of contrast echocardiography, few systematic studies have
addressed the issue of toxicity of echocardiographic contrast
agents used for myocardial perfusion imaging. Moreover,
previous studies using traditional ejection phase indexes of
left ventricular performance have yielded conflicting results
(30-33,40), These indexes such as ejection fraction, percent
fractional shortening or mean velocity of fiber shortening
reflect the net interaction of preload, afterload, heart rate
and contractile state. As such, their utility as measures of
contractility are markedly limited, Recently, several alter-
native methods of assessing left ventricular contractility have
been proposed. The most clinically promising of these relate
an index of left ventricular performance to the physiologic
forces acting on the myocardium at end-systole
(30-33,38-40). In this study, we used the relation between
end-systolic wall stress (ues> and the rate-corrected velocity
of fiber shortening (Vcf.) to assess changes in left ventricular
contractility induced by the individual echocardiographic
contrast agents independent of changes in left ventricular
loading conditions, This was possible because the U es -
Vet, relation is preload independent, incorporates heart rate
and afterload and is sensitive to alterations in left ventricular
contractility (31).
Effects of individual contrast agents on left ventric-
ular contractility. Saline. Injections of nonsonicated and
sonicated saline did not induce alterations in left ventricular
contractile state. Sonicated saline failed to opacify the myo-
cardium because microbubbles could not be suspended in
this carrier solution,
Dextrose 70%. By 15 seconds after injection, dextrose
70%, a highly viscous hyperosmolar sugar solution, in-
creased left ventricular contractility in conjunction with a
trend toward decreased afterload. This finding is consistent
with augmented contractility perhaps due to the hyperemic
response induced by the hyperosmolarity of this agent. In
favor of this hypothesis is the report of Kondo et al. (41)
who observed that intracoronary injections of hyperosmolar
glucose solutions result in a marked hyperemic effect as-
sociated with a 174% augmentation of coronary blood flow.
This suggests that the development of an ideal echocardio-
graphic contrast agent requires consideration of alterations
in both left ventricular mechanics and coronary blood flow
induced by the contrast agent itself.
Renografin-76. We have recently studied left ventricular
contractility in humans using load independent indexes dur-
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ing intracoronary injection of sonicated as well as nonson-
icated Renografin-76 (42). Injection of a volume of non-
sonicated Renografin-76 adequate for angiographic imaging
of coronary artery anatomy produced significant transient
depression in left ventricular contractility (p < 0.001 versus
control); injection of smaller volumes of sonicated echo-
cardiographic contrast agents resulted in no effect on left
ventricular contractility. In the present study. sonicated as
well as nonsonicated Renografin-76 induced at most a trivial
decrease in left ventricular afterload without causing any
alterations in left ventricular contractile state. The latter is
probably due to the small amount of Renografin-76 that
actually entered the coronary arteries during the intraaortic
root injection of contrast material. Thus. it appears that with
Renografin-76 the volume of contrast material injected rather
than the presence of microbubbles is the major determinant
of altered left ventricular hemodynamics.
Influence of bubble size on left ventricular contrac-
tility. Hand-agitated Renografin-76/saline mixture caused
a transient negative inotropic effect in conjunction with a
trend toward an increase in left ventricular afterload. This
effect was uniformly evident by 5 seconds as well as 15
seconds after injection. Ventricular contractility returned to
baseline values by 25 seconds after injection. Hand-agitated
solutions contain large, variably sized microbubbles that
may interrupt the microcirculation. Kort and Kronzon (43)
observed that hand-agitated microbubbles can obstruct ar-
terioles for a significantperiod of time before passing down-
stream. Feinstein et al. (21) observed by direct microscopic
examination of a cat mesentery preparation that large hand-
agitated microbubbles coalesce and interrupt the flow of
blood. This pluggingof the microvasculaturemaycontribute
to the acute negative inotropiceffect seen with hand-agitated
solutions in our study. When a similar volume of sonicated
Renografin-76/saline mixture was used. smaller microbub-
bles of uniform size were generated without changes in
contractility. Thus, the sonication technique should be con-
sidered as a safe and reliable method of producing small.
standardized, echocardiographic contrast agents for use in
myocardial perfusion imaging.
The light microscopic technique and the laser technique
for measuring microbubble characteristics present differ-
ences in optics and equipment design (21,34). Therefore,
the absolute microbubble diameter for a given solution may
vary based upon the method of analysis. The latter may
account for the differences in microbubble diameter found
when sonicated solutions were measured by the two meth-
ods. However, microbubble diameters are proportional when
comparing a variety of solutions using both methods.
Effect of sonication on left ventricular contractility.
In this study, injections of nonsonicated saline and nonson-
icated Renografin-76 did not alter left ventricular contrac-
tility whereas nonsonicated dextrose 70% increased con-
tractile state by 15seconds after injection. When these same
agents were sonicated before intraaortic injection. the re-
sultant effect on left ventricular contractility was identical
to that found in the absence of sonication. Thus, individual
echocardiographic contrast agents and not the addition of
sonication influenced left ventricular contractility.
Applications and limitations of this study. This study
is the initial report on the use of electrocardiographically
gated volume- and pressure-controlledaortic root injections
of small microbubbles (produced using sonication tech-
niques) as a reliable source for the introduction of contrast
agents into the coronary circulation. Using this approach.
computer analysis of videodensity was performed to estab-
lish and quantify perfusion (35). This new standardized
model for real-time myocardial perfusion imaging could be
used in the future to evaluate the effects of medical and
surgical interventions.
To interpret the data presented in this investigation sev-
eral issues should be addressed. First, all animals studied
had symmetrically contracting ventricles by two-dimen-
sional echocardiography. This allowed the use of targeted
M-rnode echocardiogramsas representative imagesof global
left ventricular contraction. Second, we used meridional
wall stress as the measure of left ventricular afterload. Al-
though circumferential wall stress may more accurately
measure the aggregate forces acting in the left ventricular
minor axis plane at any instance in time, several investi-
gators (44.45) have reported that both meridional and cir-
cumferential wall stress are major determinants of ventric-
ular performance. This finding is particularly true in the
current study in which each animal was used as its own
control. Third. though relatively small numbers of animals
were used. the results achieved highly significant p values
for key variables such as rate-corrected velocity of fiber
shortening with hand-agitated Renografin-76/saline mix-
ture. sonicated dextrose 70% and nonsonicated dextrose
70%. Finally. in this study we used a previously established
canine end-systolic stress versus rate-corrected velocity of
fiber shortening relation as a reference to assess changes in
left ventricular contractile state induced by echo contrast
agents (38). This approach seems reasonable because rel-
ative changes were assessed using each dog as its own
control.
Conclusions. Individual echocardiographic contrast agents
influence left ventricular contractility. The addition of son-
ication to a carrier solution does not further influence its
effect on contractility. Hand-agitated echocardiographic
agents, which contain relatively large microbubbles of vari-
able size. are associated with transient depression of left
ventricular contractility. The use of sonication to generate
smaller microbubbles of relatively uniform size appears to
overcome this adverse hemodynamic effect. An electrocar-
diographic-gatedpower injector with programmablevolume
and pressure variables serves as a reliable source for the
introduction of sonicated contrast agents into the coronary
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circulation by way of the aortic root. It appears that future
contrast echocardiographic studies, especially in humans,
should be performed using small volumes of carrier solu-
tions that contain relatively small, uniformly sized micro-
bubbles generated by the sonication technique.
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